Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ALT · NASDAQ · Pharmaceutical Preparations
Altimmune (ALT) · oqro.io/stocks/ALT · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$1.65+0.035 (+2.17%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 13, 2026 · Filed Nov 13, 2026
CEO purchased ~$50K of ALT shares in the open marketSourceInsider trade · Traded Nov 13, 2026 · Filed Nov 13, 2026
CFO purchased ~$16K of ALT shares in the open marketSourceInsider trade · Traded Nov 13, 2026 · Filed Nov 13, 2026
Director purchased ~$16K of ALT shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Deep Track Capital, LP disclosed a new position in ALT for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Viking Global disclosed a new position in ALT for Q2 2026SourceInsider trade · Traded Mar 17, 2025 · Filed Mar 18, 2025
Director purchased ~$5.8K of ALT shares in the open marketSourceInsider trade · Traded Mar 13, 2025 · Filed Mar 14, 2025
CFO purchased ~$52K of ALT shares in the open marketSource